StonvexLoading…
StonvexStonvexStonvexCore line items from MDLN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-31 | Q1 2025 2025-03-29 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $7.35B | $28.43B | $6.64B | $25.51B |
Operating Income | $422.00M | $2.21B | $571.00M | $2.15B |
Net Income | $239.00M | $1.16B | $319.00M | $1.16B |
EPS (Diluted) | $0.16 | $-0.01 | Not available | Not available |
Total Assets | $39.01B | $38.48B | Not available | $35.98B |
Total Liabilities | $19.66B | $19.20B | Not available | $19.45B |
Cash & Equivalents | $2.24B | $1.94B | $840.00M | $199.00M |
Free Cash Flow OCF − CapEx | $316.00M | $1.30B | $584.00M | $1.42B |
Shares Outstanding | 824.84M | 810.00M | Not available | Not available |